We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
1-Year Est. Return
41.24%
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$56.7B
AUM Growth
+$8.88B
(+19%)
Cap. Flow
+$7.92B
Cap. Flow
% of AUM
13.98%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
2,107
New
102
Increased
1,467
Reduced
463
Closed
73
Avg Time Held
24
quarters
Top 10 Avg Time Held
22.8
quarters
Top 20 Avg Time Held
20.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$779M |
| 2 |
Apple
AAPL
|
+$539M |
| 3 |
Microsoft
MSFT
|
+$522M |
| 4 |
Meta Platforms (Facebook)
META
|
+$487M |
| 5 |
Tesla
TSLA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$189M |
| 2 |
C.H. Robinson
CHRW
|
+$55.4M |
| 3 |
Fortinet
FTNT
|
+$55M |
| 4 |
AbbVie
ABBV
|
+$35.7M |
| 5 |
NextEra Energy
NEE
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Communication Services | 10.74% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Industrials | 8.58% |
| 5 | Consumer Staples | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
Health Catalyst
HCAT
$133M
| $29.5K | ﹤0.01% |
12,357
+793
| +7% | +$2.17K |
2024 Q3
5 quarters
|
|
2002
SkinHealth Systems
SKIN
$71.6M
| $29K | ﹤0.01% |
20,893
+1,341
| +7% | +$1.94K |
2021 Q2
18 quarters
|
|
2003
Braemar Hotels & Resorts
BHR
$83.1M
| $28.9K | ﹤0.01% |
10,075
-4
| -0% | -$11 |
2024 Q3
5 quarters
|
|
2004
MaxCyte
MXCT
$104M
| $28.7K | ﹤0.01% |
18,529
-2,561
| -12% | -$4.09K |
2022 Q1
15 quarters
|
|
2005
Satellogic
SATL
$792M
| $28.7K | ﹤0.01% |
15,349
+3,561
| +30% | +$7.7K |
2025 Q2
2 quarters
|
|
2006
DELISTED
Open Lending Corp
LPRO
| $28.6K | ﹤0.01% |
18,481
+951
| +5% | +$1.69K |
2021 Q2
18 quarters
|
|
2007
SKYX Platforms
SKYX
$149M
| $28.4K | ﹤0.01% |
13,086
+2,482
| +23% | +$4.43K |
2025 Q2
2 quarters
|
|
2008
Outdoor Holding Co
POWW
$259M
| $27.1K | ﹤0.01% |
15,847
+1,019
| +7% | +$1.75K |
2022 Q4
12 quarters
|
|
2009
Kaltura
KLTR
$201M
| $27.1K | ﹤0.01% |
16,495
+1,059
| +7% | +$1.67K |
2023 Q2
10 quarters
|
|
2010
DELISTED
GETTY IMAGES HLDGS INC A
GETY
| $27K | ﹤0.01% |
20,117
+1,288
| +7% | +$2.22K |
2024 Q3
5 quarters
|
|
|
FFAI
2011
Faraday Future Intelligent Electric
FFAI
$6.74M
| $26.6K | ﹤0.01% |
174
+70
| +67% | +$13K |
2025 Q2
2 quarters
|
|
2012
Stereotaxis
STXS
$111M
| $25.4K | ﹤0.01% |
11,065
+559
| +5% | +$1.49K |
2024 Q3
5 quarters
|
|
2013
Protalix BioTherapeutics
PLX
$224M
| $23.6K | ﹤0.01% |
13,137
+1,215
| +10% | +$2.48K |
2025 Q2
2 quarters
|
|
2014
Zevia
ZVIA
$87.3M
| $23.5K | ﹤0.01% |
+10,150
| New | +$25.2K |
2025 Q4
0 quarters
|
|
2015
Alector
ALEC
$232M
| $22.9K | ﹤0.01% |
14,672
-759
| -5% | -$1.35K |
2019 Q4
24 quarters
|
|
2016
Patriot National Bancorp
PNBK
$111M
| $22.8K | ﹤0.01% |
+12,524
| New | +$17.3K |
2025 Q4
0 quarters
|
|
2017
Inhibikase Therapeutics
IKT
$275M
| $22.6K | ﹤0.01% |
11,046
+705
| +7% | +$1.12K |
2025 Q2
2 quarters
|
|
2018
Montauk Renewables
MNTK
$360M
| $20.5K | ﹤0.01% |
12,291
+785
| +7% | +$1.51K |
2024 Q3
5 quarters
|
|
2019
Fate Therapeutics
FATE
$261M
| $19.5K | ﹤0.01% |
19,872
-2,831
| -12% | -$3.4K |
2018 Q4
28 quarters
|
|
2020
BRC Inc
BRCC
$138M
| $18.8K | ﹤0.01% |
1,690
+36
| +2% | +$467 |
2024 Q4
4 quarters
|
|
2021
Lucid Diagnostics
LUCD
$122M
| $18K | ﹤0.01% |
16,471
+4,320
| +36% | +$4.83K |
2025 Q2
2 quarters
|
|
2022
Hain Celestial
HAIN
$50.4M
| $17.7K | ﹤0.01% |
16,541
+1,063
| +7% | +$1.31K |
2020 Q3
21 quarters
|
|
2023
Expensify
EXFY
$219M
| $16.5K | ﹤0.01% |
10,923
+698
| +7% | +$1.11K |
2025 Q2
2 quarters
|
|
2024
Eledon Pharmaceuticals
ELDN
$202M
| $15.5K | ﹤0.01% |
+10,266
| New | +$24.4K |
2025 Q4
0 quarters
|
|
2025
Advantage Solutions
ADV
$388M
| $15.2K | ﹤0.01% |
689
+44
| +7% | +$1.27K |
2023 Q2
10 quarters
|
|
Similar funds
ProShare Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, ProShare Advisors held 2,107 positions worth $56.7B, up 19% from $47.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
ProShare Advisors deployed $7.92B of net new capital in Q4 2025, opening 102 new positions and adding to 1,467 existing holdings. Its largest new stake was CRH: 131,018 shares worth $16.4M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $189M trimmed.
- ProShare Advisors's largest Q4 2025 buy was CRH: 131,018 shares worth $16.4M.
- ProShare Advisors added most to NVIDIA in Q4 2025, an estimated $779M increase.
- ProShare Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $189M.
- ProShare Advisors fully exited Perrigo in Q4 2025, selling an estimated $27.6M.
- ProShare Advisors's ten largest holdings make up 34% of its $56.7B portfolio in Q4 2025.
- ProShare Advisors opened 102 new positions and closed 73 in Q4 2025.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $56.7B.
Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.